Time to Change Guidelines for Laboratory Monitoring During Isotretinoin Treatment

Abstract

Keywords

acne vulgaris isotretinoin laboratory monitoring leukopenia hypertriglyceridemia

Get full access to this article

View all access options for this article.

References

Czilli

Tan

Knezevic

Peters

. Cost of medications recommended by Canadian acne clinical practice guidelines. J Cutan Med Surg. 2016;20(6):542-545.doi:10.1177/1203475416653735

Tan

Knezevic

Boyal

Waterman

Janik

. Evaluation of evidence for acne remission with oral isotretinoin cumulative dosing of 120-150 mg/kg. J Cutan Med Surg. 2016;20(1):13-20.doi:10.1177/1203475415595776

Asai

Baibergenova

Dutil

et al. Management of acne: Canadian clinical practice guideline. Can Med Assoc J. 2016;188(2):118-126.doi:10.1503/cmaj.140665

Zaenglein

AL.

Pathy

AL.

Schlosser

et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973.doi:10.1016/j.jaad.2015.12.037

Barbieri

JS.

Shin

DB.

Wang

Margolis

DJ.

Takeshita

. The clinical utility of laboratory monitoring during isotretinoin therapy for acne and changes to monitoring practices over time. J Am Acad Dermatol. 2019.doi:10.1016/j.jaad.2019.06.025

Lee

YH.

Scharnitz

TP.

Muscat

Chen

Gupta-Elera

Kirby

. Laboratory monitoring during isotretinoin therapy for acne: a systematic review and meta-analysis. JAMA Dermatol. 2016;152(1):35-44.doi:10.1001/jamadermatol.2015.3091

Öktem

Hayran

Arı

Yalçın

. Minimize the regular laboratory monitoring during the systemic isotretinoin treatment: data of 704 patients with acne vulgaris. J Dermatolog Treat. 2019;16:1-5.doi:10.1080/09546634.2019.1591578